Diversion to Treatment for Injection Drug Users Arrested for Possession of Heroin
Cocaine-Related Disorders, HIV, Heroin Dependence

About this trial
This is an interventional treatment trial for Cocaine-Related Disorders focused on measuring Cocaine, Heroin, HIV, Contingency Management, Incentives, Criminal Justice, Methadone, Buprenorphine, Employment, Job Training, Wage Subsidies
Eligibility Criteria
Inclusion Criteria:
- report using heroin at least 20 of the last 30 days of living in the community
- meet criteria for methadone maintenance (at least one year of meeting DSM IV criteria for heroin dependence)
- have visible track marks or other clear physical evidence of injection drug use
- report using cocaine in the last 30 days
- were unemployed prior to arrest
- have a income below the federal poverty level
- live in the Baltimore City area
Exclusion Criteria:
- report current suicidal ideation or hallucinations
- receiving opioid pharmacotherapy prior to arrest
- have a serious uncontrolled medical condition that would prevent attendance in methadone or buprenorphine treatment
- are pregnant or breastfeeding
- have a physical imparement that would prevent typing
Sites / Locations
- Center for Learning and Health
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Therapeutic Workplace
Diversion to treatment (Usual Care)
Participants assigned to this condition will receive the standard services and requirements for diversion as described for the usual care group, and will also be eligible to attend the three-phase Therapeutic Workplace (TW) intervention. All phases of this intervention include employment-based drug abstinence reinforcement contingencies. Under these contingencies, participants can work and earn wages or wage subsidies contingent upon drug abstinence as verified by urinalysis. Phase 1 of the TW intervention is expected to increase cocaine abstinence and to prepare participants for employment. Phase 2 of the TW intervention is expected to maintain abstinence while participants are employed in an onsite model workplace. Phase 3 is designed to increase employment in community jobs and to maintain abstinence while participants are employed in offsite community workplaces.
Participants in this condition will be offered the standard treatment services available in community methadone and buprenorphine programs, including medication (methadone or buprenorphine, respectively), counseling services, HIV testing, and case management. All services will be provided in the treatment clinics. There are a number of clinics within easy walking distance from the research site, and others throughout the city that are reachable by public transportation from the research site. In addition, all participants will receive referrals to the Re-Entry Center, a One-Stop Career Center tailored to the needs of offenders, at all intake and monthly assessments. As mentioned in detail above, participants will be required by the court to stay enrolled in treatment for 90 days. It is important to note that all diverted individuals will receive these services and requirements, independent of whether they agree to participate in the pilot study.